These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3028718)

  • 1. T-lymphocytes subpopulation before and after surgical removal of hepatocellular carcinoma.
    Lee CS; Lin TY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):27-33. PubMed ID: 3028718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphocytes subpopulations in peripheral blood of hepatocellular carcinoma patients.
    Lee CS; Lin TY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 May; 17(2):92-7. PubMed ID: 6088184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma.
    Wu TT; Hsu HC; Chen DS; Sheu JC; Su IJ; Chen SL; Chuang SM
    J Hepatol; 1987 Feb; 4(1):45-51. PubMed ID: 3033059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T-cell subsets in chronic type B hepatitis: correlation with biochemical and histological activities and hepatitis B e antigen/antibody status.
    Chu CM; Liaw YF; Yang CY; Sheen IS
    Cell Immunol; 1984 Jul; 86(2):562-6. PubMed ID: 6234072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in hepatocellular carcinoma patients.
    Lee CS; Lee FZ
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):478-82. PubMed ID: 2551994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytes and their subsets in the peripheral blood of hepatocellular carcinoma patients.
    Lee CS
    J Formos Med Assoc; 1991 Jul; 90(7):626-30. PubMed ID: 1681011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers.
    Chu CM; Liaw YF
    Cell Immunol; 1986 Apr; 98(2):533-7. PubMed ID: 3489555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection.
    Barnaba V; Musca A; Cordova C; Levrero M; Ruocco G; Albertini-Petroni V; Balsano F
    Clin Exp Immunol; 1983 Aug; 53(2):281-8. PubMed ID: 6224609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF; Jeng LB; Lee WC; Chen TC
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection.
    Barnaba V; Levrero M; Van Dyke AD; Musca A; Cordova C; Balsano F
    Clin Immunol Immunopathol; 1985 Mar; 34(3):284-95. PubMed ID: 2578908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
    Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
    Lin X; Qian GS; Lu PX; Wu L; Wen YM
    J Med Virol; 2001 Jul; 64(3):299-304. PubMed ID: 11424118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte transformation in patients with HBsAg-positive chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Chuang WL; Chang WY; Wang LY; Tsai JF; Hsieh MY; Chen SC; Chiang W; Liu WJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):557-61. PubMed ID: 2551996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma.
    Wu CC; Ho WL; Chen JT; Tang JS; Yeh DC; P'eng FK
    Br J Surg; 1999 Nov; 86(11):1391-6. PubMed ID: 10583284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
    Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
    West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HBeAg in the lymphocytes of sero-HBeAg negative patients with chronic hepatitis B and primary hepatocellular carcinoma.
    Ding JL; Oon CJ
    Cytobios; 1984; 39(153):29-33. PubMed ID: 6323101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.